Clinical Trial Update: CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update notes that an early-phase study is recruiting to evaluate CYTALUX (pafolacianine) injection for intraoperative near-infrared fluoresc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Cytalux (pafolacianine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Endometrial Cancer, Near Infrared Fluorescence Imaging | EARLY_Phase 1 | Status: RECRUITING